A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV)
Pre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necessary knowledge, skills and attitudes to effectively...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-05-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/8/2/84 |
| _version_ | 1797568259484024832 |
|---|---|
| author | Kyle J. Wilby Alesha J. Smith |
| author_facet | Kyle J. Wilby Alesha J. Smith |
| author_sort | Kyle J. Wilby |
| collection | DOAJ |
| description | Pre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necessary knowledge, skills and attitudes to effectively provide care to PrEP patients. The aim of this review was to identify priority areas and key gaps for continuing professional development (CPD) needs relating to PrEP for practicing pharmacists. An electronic search of PubMed, EMBASE, International Pharmaceutical Abstracts and CPD-related journals was supplemented with a manual search of references to identify articles describing pharmacists’ knowledge, perceptions and experience with PrEP. A total of eight articles were identified across four countries. Pharmacists were consistently found to lack knowledge and awareness of PrEP, express low confidence/comfort with patient care practices, report a lack of experience and/or intentions to provide patient care, but overall had positive perceptions of PrEP therapy. Older pharmacists with more experience commonly reported greater knowledge gaps than recently trained pharmacists. CPD should therefore aim to increase pharmacists’ baseline knowledge and awareness of PrEP and treatment guidelines, as well as be directed towards older pharmacists with more experience. |
| first_indexed | 2024-03-10T19:53:54Z |
| format | Article |
| id | doaj.art-ccac607e9212405da124115056b71c92 |
| institution | Directory Open Access Journal |
| issn | 2226-4787 |
| language | English |
| last_indexed | 2024-03-10T19:53:54Z |
| publishDate | 2020-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj.art-ccac607e9212405da124115056b71c922023-11-20T00:07:41ZengMDPI AGPharmacy2226-47872020-05-01828410.3390/pharmacy8020084A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV)Kyle J. Wilby0Alesha J. Smith1School of Pharmacy, University of Otago, Dunedin 9054, New ZealandSchool of Pharmacy, University of Otago, Dunedin 9054, New ZealandPre-exposure prophylaxis (PrEP) for the human immunodeficiency virus (HIV) is rapidly increasing in use worldwide, with many countries now publicly funding use for high risk populations. Pharmacists, as front-line care providers, must have the necessary knowledge, skills and attitudes to effectively provide care to PrEP patients. The aim of this review was to identify priority areas and key gaps for continuing professional development (CPD) needs relating to PrEP for practicing pharmacists. An electronic search of PubMed, EMBASE, International Pharmaceutical Abstracts and CPD-related journals was supplemented with a manual search of references to identify articles describing pharmacists’ knowledge, perceptions and experience with PrEP. A total of eight articles were identified across four countries. Pharmacists were consistently found to lack knowledge and awareness of PrEP, express low confidence/comfort with patient care practices, report a lack of experience and/or intentions to provide patient care, but overall had positive perceptions of PrEP therapy. Older pharmacists with more experience commonly reported greater knowledge gaps than recently trained pharmacists. CPD should therefore aim to increase pharmacists’ baseline knowledge and awareness of PrEP and treatment guidelines, as well as be directed towards older pharmacists with more experience.https://www.mdpi.com/2226-4787/8/2/84pharmacycontinuing educationcontinuing professional developmentHIVpre-exposure prophylaxisantiretrovirals |
| spellingShingle | Kyle J. Wilby Alesha J. Smith A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Pharmacy pharmacy continuing education continuing professional development HIV pre-exposure prophylaxis antiretrovirals |
| title | A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) |
| title_full | A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) |
| title_fullStr | A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) |
| title_full_unstemmed | A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) |
| title_short | A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) |
| title_sort | narrative review of continuing professional development needs for pharmacists with respect to pre exposure prophylaxis prep for human immunodeficiency virus hiv |
| topic | pharmacy continuing education continuing professional development HIV pre-exposure prophylaxis antiretrovirals |
| url | https://www.mdpi.com/2226-4787/8/2/84 |
| work_keys_str_mv | AT kylejwilby anarrativereviewofcontinuingprofessionaldevelopmentneedsforpharmacistswithrespecttopreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT aleshajsmith anarrativereviewofcontinuingprofessionaldevelopmentneedsforpharmacistswithrespecttopreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT kylejwilby narrativereviewofcontinuingprofessionaldevelopmentneedsforpharmacistswithrespecttopreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT aleshajsmith narrativereviewofcontinuingprofessionaldevelopmentneedsforpharmacistswithrespecttopreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv |